
DSPE-NHS
CAS No. 1383932-86-2
DSPE-NHS( —— )
Catalog No. M36848 CAS No. 1383932-86-2
DSPE-NHS is a lipid that is often combined with other compounds to form nanoemulsions that can be used in skin care products and pharmaceuticals.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 38 | Get Quote |
![]() ![]() |
10MG | 61 | Get Quote |
![]() ![]() |
25MG | 104 | Get Quote |
![]() ![]() |
50MG | 165 | Get Quote |
![]() ![]() |
100MG | 260 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameDSPE-NHS
-
NoteResearch use only, not for human use.
-
Brief DescriptionDSPE-NHS is a lipid that is often combined with other compounds to form nanoemulsions that can be used in skin care products and pharmaceuticals.
-
DescriptionDSPE-NHS is a bioconjugation phospholipid molecule with two hydrophobic lipid tails. The NHS-ester is reactive with N-terminal of protein/peptide or other amine molecule to form a stable amide linkage. DSPE-NHS is a self-assembling reagent which forms lipid bilayer in aqueous solution. DSPE-NHS can be used to prepare liposomes as agent nanocarrier.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1383932-86-2
-
Formula Weight945.21
-
Molecular FormulaC49H89N2O13P
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO(C(CCC(NCCOP(OC[C@@H](COC(CCCCCCCCCCCCCCCCC)=O)OC(CCCCCCCCCCCCCCCCC)=O)(=O)O)=O)=O)N1C(=O)CCC1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Mikio Tatsutomi, et al. Preparation of a nitric oxide imaging agent from gelatin derivative micelles. Regen Ther. 2016 Sep 14;5:64-71.?
molnova catalog



related products
-
Ethacridine lactate
Ethacridine lactate is a poly(ADP-ribose) glycohydrolase (PARG) inhibitor.
-
2-O-Methylphloretin ...
The peels of apple.
-
Integerrimine
Prenatal exposure to Integerrimine N-oxide induces maternal toxicity, impairment of maternal care and delayed in physical and behavioral development of the offspring. Doses of Integerrimine N-oxide here employed did not produce marked immunotoxic effects.